• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Endocrinology

Cranial radiotherapy associated with increased risk of anterior hypopituitarism

byMonica ParksandDavid Wang
January 12, 2015
in Endocrinology, Imaging and Intervention, Oncology
Reading Time: 3 mins read
Cranial radiotherapy associated with increased risk of anterior hypopituitarism
Share on FacebookShare on TwitterShare on LinkedIn

1. In a retrospective review of over 700 childhood cancer survivors (CCS) treated with cranial radiotherapy, over 50% developed anterior pituitary dysfunction.

2. A significant number of CCS who developed growth hormone and sex-hormone deficiencies were not recognized, leading to serious cardiovascular and musculoskeletal morbidities.

Evidence Rating Level: 3 (Average)  

Study Rundown: Anterior hypopituitarism is a known complication of cranial radiotherapy (CRT) for childhood malignancies. The risk of anterior pituitary dysfunction in childhood cancer survivors (CCS) increases in a time-dependent fashion and patients with unrecognized deficiencies may demonstrate significant morbidity in adulthood. The purpose of this study is to describe the long-term health outcomes and complications of this patient population. The authors retrospectively analyzed over 700 patients treated with CRT. After an average follow-up of 27.3 years, the authors found that over 50% of patients had at least one anterior pituitary deficiency with growth hormone deficiency (GHD) and luteinizing/follicular stimulating hormone deficiency (LH/FSHD) being the most common. Furthermore, the majority of individuals with GHD and LH/FSHD did not receive replacement hormone therapy, which led to significantly increased complications including decreased muscle mass and exercise tolerance, hypertension, dyslipidemia, and low bone mineral index compared to a reference population. Risk factors for the development of anterior hypopituitarism included male sex, obesity, white race, and increasing doses of radiation. This is the largest patient cohort following the development of anterior pituitary complications in CCS and the results of this trial support the hypothesis of lifetime screening for this patient population. The main limitation of this trial is the retrospective study design and the use of static endocrine testing sectional data.

Click to read the study in the JCO (Journal of Clinical Oncology)

Relevant Reading: Hypothalamic-pituitary dysfunction after radiation for brain tumors

RELATED REPORTS

Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy 

Prophylactic Radiation Therapy for High-Risk Asymptomatic Bone Metastases

In-Depth [retrospective cohort]: The authors performed a retrospective study of a long-term cohort of childhood cancer survivors from the St. Jude Lifetime Cohort (SJLIFE) study. A total of 748 patients (mean age: 27.3 years; range: 10.8 to 47.7 years) who had undergone CRT were observed for a mean duration of 27.3 years (range 10.8 to 47.7 years). Overall, 51.4% (n=371) patients had one of four anterior pituitary deficiencies; 46.5% (n=348) of patients had growth hormone deficiency (GHD), 10.8% (n=79) had luteinizing hormone/follicular stimulating hormone deficiency (LH/FSHD), 7.5% (n=56) with thyroid stimulating hormone deficiency (TSHD), and 4% (n=29) with ACTH deficiency. Only 1 (0.3%) individual with GHD and 17 (21.5%) patients with LH/FSHD were receiving hormone replacement therapy. Untreated GHD was associated with decreased muscle mass and exercise tolerance, while untreated LH/FSHD was associated with hypertension, dyslipidemia, low bone mineral density and slow walking. Male sex and obesity were associated with LH/FSHD, and white race with LH/FSHD and TSHD. CRT doses of 22-29.9 Gy were associated with GHD compared to doses less than 22 Gy, and doses >30 Gy were associated with TSHD and ACTHD.

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: anterior pituitary dysfunctionpediatric oncologyRadiation Oncology
Previous Post

Researchers test lower-toxicity chemotherapy for women with early-stage breast cancers

Next Post

Low rotavirus vaccination coverage associated with ongoing disease transmission

RelatedReports

Cardiology

Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy 

October 15, 2024
Radiation therapy collage: an older woman in a calm portrait beside the curved arm of a treatment machine and a mesh mask
Oncology

Prophylactic Radiation Therapy for High-Risk Asymptomatic Bone Metastases

October 2, 2023
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Chronic Disease

Dose-escalated simultaneous integrated boost radiotherapy may increase ipsilateral breast tumor relapse rates

July 12, 2023
Chronic Disease

Simultaneous integrated boost radiation therapy may improve survival rates for esophageal squamous cell carcinoma

May 26, 2023
Next Post
Low rotavirus vaccination coverage associated with ongoing disease transmission

Low rotavirus vaccination coverage associated with ongoing disease transmission

Head Start linked to healthy changes in BMI

Head Start linked to healthy changes in BMI

Esmolol-induced heart rate reduction may aid in septic shock

Withholding and withdrawing care viewed as different among Asian intensivists

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • AI Model Shows Promise in Predicting PTSD Risk Following Trauma
  • 2 Minute Medicine Rewind November 16, 2026
  • ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.